236 related articles for article (PubMed ID: 29222241)
1. Inherited bone marrow failure syndromes: considerations pre- and posttransplant.
Alter BP
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):88-95. PubMed ID: 29222241
[TBL] [Abstract][Full Text] [Related]
2. Inherited bone marrow failure syndromes: considerations pre- and posttransplant.
Alter BP
Blood; 2017 Nov; 130(21):2257-2264. PubMed ID: 29167174
[TBL] [Abstract][Full Text] [Related]
3. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2018 Jan; 103(1):30-39. PubMed ID: 29051281
[TBL] [Abstract][Full Text] [Related]
4. Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.
Tamary H; Nishri D; Yacobovich J; Zilber R; Dgany O; Krasnov T; Aviner S; Stepensky P; Ravel-Vilk S; Bitan M; Kaplinsky C; Ben Barak A; Elhasid R; Kapelusnik J; Koren A; Levin C; Attias D; Laor R; Yaniv I; Rosenberg PS; Alter BP
Haematologica; 2010 Aug; 95(8):1300-7. PubMed ID: 20435624
[TBL] [Abstract][Full Text] [Related]
5. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.
Savage SA; Dufour C
Semin Hematol; 2017 Apr; 54(2):105-114. PubMed ID: 28637614
[TBL] [Abstract][Full Text] [Related]
6. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
Dietz AC; Savage SA; Vlachos A; Mehta PA; Bresters D; Tolar J; Bonfim C; Dalle JH; de la Fuente J; Skinner R; Boulad F; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1422-1428. PubMed ID: 28533057
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
[TBL] [Abstract][Full Text] [Related]
8. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
[TBL] [Abstract][Full Text] [Related]
9. Inherited bone marrow failure syndromes in adolescents and young adults.
Wilson DB; Link DC; Mason PJ; Bessler M
Ann Med; 2014 Sep; 46(6):353-63. PubMed ID: 24888387
[TBL] [Abstract][Full Text] [Related]
10. Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes.
West AH; Churpek JE
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):79-87. PubMed ID: 29222240
[TBL] [Abstract][Full Text] [Related]
11. Inherited bone marrow failure syndromes: molecular features.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2006; ():63-71. PubMed ID: 17124042
[TBL] [Abstract][Full Text] [Related]
12. Posttransplant complications in patients with marrow failure syndromes: are we improving long-term outcomes?
Hudda Z; Myers KC
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):141-148. PubMed ID: 38066882
[TBL] [Abstract][Full Text] [Related]
13. Treatment of inherited bone marrow failure syndromes beyond transplantation.
Calado RT; Clé DV
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):96-101. PubMed ID: 29222242
[TBL] [Abstract][Full Text] [Related]
14. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.
Alter BP; Giri N; Savage SA; Peters JA; Loud JT; Leathwood L; Carr AG; Greene MH; Rosenberg PS
Br J Haematol; 2010 Jul; 150(2):179-88. PubMed ID: 20507306
[TBL] [Abstract][Full Text] [Related]
15. Congenital disorders of ribosome biogenesis and bone marrow failure.
Sakamoto KM; Shimamura A; Davies SM
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S12-7. PubMed ID: 19770060
[TBL] [Abstract][Full Text] [Related]
16. Ribosomes and marrow failure: coincidental association or molecular paradigm?
Liu JM; Ellis SR
Blood; 2006 Jun; 107(12):4583-8. PubMed ID: 16507776
[TBL] [Abstract][Full Text] [Related]
17. Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes.
Bonfim C
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):107-114. PubMed ID: 33275667
[TBL] [Abstract][Full Text] [Related]
18. Telomere length in inherited bone marrow failure syndromes.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
Dalle JH; Peffault de Latour R
Int J Hematol; 2016 Apr; 103(4):373-9. PubMed ID: 26872907
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes.
Sakaguchi H; Yoshida N
Int J Hematol; 2022 Jul; 116(1):16-27. PubMed ID: 35633493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
